ZURICH: US biotech firm Regeneron and its Swiss partner Roche unveiled promising clinical trial results on Monday indicating that an antibody treatment used to treat Covid-19 patients also helps prevent infections. The results of the Phase 3 trial showed that the combination of the antibodies casirivimab and imdevimab dramatically reduced the risk of symptomatic infection among people living with Covid-19 patients, Roche said in a statement.
Chief minister of Indian province Tamil Nadu MK Stalin. — NNI/FileNEW DELHI: The chief minister of Tamil Nadu...
US president-elect Donald Trump. — AFP/FileNEW YORK: A New York appellate court on Tuesday denied President-elect...
Representational image of police tape at an incident site. — Unsplash/FileLONDON: A 14-year-old boy was stabbed to...
UK Prime Minister Keir Starmer.— Reuters/File LONDON: UK Prime Minister Keir Starmer said on Tuesday his government...
Donald Trump attends the Oakland County GOP Lincoln Day Dinner in Novi, Michigan, US, June 25, 2023. — ReutersPALM...
Iranian forces standing alert during a drill near the Natanz. — Reuters/FileTEHRAN: Iran´s military has begun...
